» Articles » PMID: 35338435

Risk Factors for Mechanical Ventilation in Patients with Guillain-Barré Syndrome

Overview
Journal Neurocrit Care
Specialty Critical Care
Date 2022 Mar 26
PMID 35338435
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Respiratory support is required in 20-30% of patients with Guillain-Barré syndrome (GBS). We investigated clinical and biological risk factors for mechanical ventilation (MV) in northeast China through a retrospective GBS study. The Erasmus GBS Respiratory Insufficiency Score (EGRIS) is a prognostic model for MV in patients with GBS, and its usefulness has been validated in several countries but not in China. Therefore, we intended to validate the EGRIS model in our GBS cohort.

Methods: A total of 252 patients with GBS were included in this study from January 2013 to October 2017. Risk factors for MV were identified via multivariate logistic regression analysis. The prognostic value of the EGRIS was validated via receiver operating characteristic curve analysis.

Results: Thirty-one patients (12.3%) required MV (mean age 54.19 years), with a majority being male (77.4%). The risk factors for MV were male sex [odds ratio (OR) 3.720, 95% confidence interval (CI) 1.155-11.985, p < 0.05], shorter interval from onset to admission (OR 0.830, 95% CI 0.711-0.970, p < 0.05), lower Medical Research Council sum score at admission (OR 0.942, 95% CI 0.911-0.973, p < 0.001), neutrophil-to-lymphocyte ratio at admission (OR 1.174, 95% CI 1.049-1.315, p < 0.01), and cranial nerve deficit (OR 3.805, 95% CI 1.373-10.541, p < 0.05). The EGRIS had a good predictive ability for MV (area under the receiver operating curve 0.861) in patients with GBS, and a high EGRIS was a predictor for MV (OR 8.778, 95% CI 3.432-22.448, p < 0.001). However, there was no significant difference in ganglioside administration between ventilated and nonventilated patients.

Conclusions: An elevated neutrophil-to-lymphocyte ratio at admission and a high EGRIS could serve as predictors for MV in our GBS cohort.

Citing Articles

Predictors of respiratory failure in Guillain-Barré syndrome: a 22 year cohort study from a single Italian centre.

Galassi G, Mazzoli M, Ariatti A, Bedin R, Marzullo D, Bastia E Eur J Neurol. 2023; 31(1):e16090.

PMID: 37823704 PMC: 11235807. DOI: 10.1111/ene.16090.


Predicting of Mechanical Ventilation and Outcomes by Using Models and Biomarker in Guillain-Barré Syndrome.

Yao J, Zhou R, Liu Y, Liu Y, Cao Q, Lu Z Neurol Ther. 2023; 12(6):2121-2132.

PMID: 37792219 PMC: 10630181. DOI: 10.1007/s40120-023-00546-w.


An Analysis of Respiratory Muscle Paralysis of Adult Patients in Guillain-Barré Syndrome: A Retrospective Analysis.

Wang A, Wang X, Wang X, Li G, Zhong D Medicina (Kaunas). 2023; 59(7).

PMID: 37512077 PMC: 10384571. DOI: 10.3390/medicina59071267.


Role of the Neutrophil to Lymphocyte Ratio in Guillain Barré Syndrome: A Systematic Review and Meta-Analysis.

Sarejloo S, Khanzadeh S, Hosseini S, Gargari M, Lucke-Wold B, Mosalamiaghili S Mediators Inflamm. 2022; 2022:3390831.

PMID: 36133742 PMC: 9484954. DOI: 10.1155/2022/3390831.

References
1.
Wu X, Wu W, Wang Z, Shen D, Pan W, Wang Y . More severe manifestations and poorer short-term prognosis of ganglioside-associated Guillain-Barré syndrome in Northeast China. PLoS One. 2014; 9(8):e104074. PMC: 4118971. DOI: 10.1371/journal.pone.0104074. View

2.
Wakerley B, Yuki N . Infectious and noninfectious triggers in Guillain-Barré syndrome. Expert Rev Clin Immunol. 2013; 9(7):627-39. DOI: 10.1586/1744666X.2013.811119. View

3.
Figueras A, Morales-Olivas F, Capella D, Palop V, Laporte J . Bovine gangliosides and acute motor polyneuropathy. BMJ. 1992; 305(6865):1330-1. PMC: 1883909. DOI: 10.1136/bmj.305.6865.1330. View

4.
Islam Z, Papri N, Ara G, Ishaque T, Alam A, Jahan I . Risk factors for respiratory failure in Guillain-Barré syndrome in Bangladesh: a prospective study. Ann Clin Transl Neurol. 2019; 6(2):324-332. PMC: 6389747. DOI: 10.1002/acn3.706. View

5.
Green C, Baker T, Subramaniam A . Predictors of respiratory failure in patients with Guillain-Barré syndrome: a systematic review and meta-analysis. Med J Aust. 2018; 208(4):181-188. DOI: 10.5694/mja17.00552. View